Euphoriants

White Glove Cannabis Delivery Service, Emjay, Officially Launches In Los Angeles

Retrieved on: 
Thursday, March 21, 2019
Cannabis, Cannabis smoking, Entheogens, Euphoriants, Medicine, Medical specialties, Psychoactive drugs

LOS ANGELES, March 21, 2019 /PRNewswire/ -- Emjay launches today in Los Angeles as a premier cannabis delivery service catering to cannabis enthusiasts and recreational users across the city.

Key Points: 
  • LOS ANGELES, March 21, 2019 /PRNewswire/ -- Emjay launches today in Los Angeles as a premier cannabis delivery service catering to cannabis enthusiasts and recreational users across the city.
  • Products available on the platform include goods from high-end cannabis companies Beboe, Bloom Farms, Kiva, and Sherbinskis.
  • Emjay joins the luxury specialty retailer as its exclusive white glove delivery service for cannabis products at "The High End," a first-of-its-kind cannabis lifestyle and wellness concept shop.
  • Whether you're new to cannabis or a seasoned "cannoisseur," we discover, test and curate the best products in the market.

Canada Cannabis Market Report 2019 Featuring AbbVie, Alita, Anheuser-Busch, Aurora, Canopy & Tilray

Retrieved on: 
Thursday, March 21, 2019
Medicinal plants, Medicine, Herbalism, Entheogens, Euphoriants, Health sciences, Health, Cannabis, Medical cannabis, Cannabis in Canada, Decriminalization of non-medical cannabis in the United States

DUBLIN, March 21, 2019 /PRNewswire/ -- The "Cannabis Market: Canada's Legalization of Recreational Marijuana is Boosting the Fortunes of Cannabis Stocks" report has been added to ResearchAndMarkets.com's offering.

Key Points: 
  • DUBLIN, March 21, 2019 /PRNewswire/ -- The "Cannabis Market: Canada's Legalization of Recreational Marijuana is Boosting the Fortunes of Cannabis Stocks" report has been added to ResearchAndMarkets.com's offering.
  • The cannabis market has great potential for generating more profits for investors and companies in the future.
  • The industry has grown massively following the legalization of recreational cannabis use in Canada, making the country the trading center for legal marijuana in the world.
  • In the stock market, due to the nature of their business Cannabis stocks have been very volatile making them a risky investment at present.

Scientists Intensify Research on Key Chemical Structures Within Cannabis

Retrieved on: 
Thursday, March 21, 2019
Entheogens, Euphoriants, Drugs, Medicine, Cannabis, Medicinal plants, Herbs, Herbalism, Hemp, Medical cannabis, Cannabidiol, Tetrahydrocannabinol

However, the CDC also mentioned that there isn't enough large-scale research being done in order to consider cannabis as a registered medicine.

Key Points: 
  • However, the CDC also mentioned that there isn't enough large-scale research being done in order to consider cannabis as a registered medicine.
  • However, despite the lack of large-scale research, the FDA has already approved a cannabis-based drug, Epidiolex.
  • However, both marijuana and hemp are derived from the Cannabis sativa family, but their genetic makeup causes very different effects.
  • Marijuana is most commonly associated with the THC chemical compound, which causes a euphoric body high while hemp is primarily linked with CBD, which provides a more relaxing effect.

Financial Institutions Enticed to Enter the Developing Cannabis Market

Retrieved on: 
Thursday, March 21, 2019
Medicinal plants, Medicine, Herbalism, Entheogens, Euphoriants, Health sciences, Plants, Cannabis law, Cannabis, Medical cannabis, Legality of cannabis

So far, only Canada and Uruguay have decided to legalize cannabis entirely, yet, the U.S. is still the biggest market driver.

Key Points: 
  • So far, only Canada and Uruguay have decided to legalize cannabis entirely, yet, the U.S. is still the biggest market driver.
  • Overall, as more states and countries move to legalize cannabis, cannabis is expected to flourish and become the next disruptive global market.
  • The investors see the potential for the cannabis industry despite the market being in a very grey area, legally.
  • HEXO Corp. (NYSE: HEXO) (TSX: HEXO) is an award-winning consumer packaged goods cannabis company that creates and distributes prize-winning products to serve the global cannabis market.

Scientists Intensify Research on Key Chemical Structures Within Cannabis

Retrieved on: 
Thursday, March 21, 2019
Entheogens, Euphoriants, Drugs, Medicine, Cannabis, Medicinal plants, Herbs, Herbalism, Hemp, Medical cannabis, Cannabidiol, Tetrahydrocannabinol

However, the CDC also mentioned that there isn't enough large-scale research being done in order to consider cannabis as a registered medicine.

Key Points: 
  • However, the CDC also mentioned that there isn't enough large-scale research being done in order to consider cannabis as a registered medicine.
  • However, despite the lack of large-scale research, the FDA has already approved a cannabis-based drug, Epidiolex.
  • However, both marijuana and hemp are derived from the Cannabis sativa family, but their genetic makeup causes very different effects.
  • Marijuana is most commonly associated with the THC chemical compound, which causes a euphoric body high while hemp is primarily linked with CBD, which provides a more relaxing effect.

Financial Institutions Enticed to Enter the Developing Cannabis Market

Retrieved on: 
Thursday, March 21, 2019
Medicinal plants, Medicine, Herbalism, Entheogens, Euphoriants, Health sciences, Plants, Cannabis law, Cannabis, Medical cannabis, Legality of cannabis

So far, only Canada and Uruguay have decided to legalize cannabis entirely, yet, the U.S. is still the biggest market driver.

Key Points: 
  • So far, only Canada and Uruguay have decided to legalize cannabis entirely, yet, the U.S. is still the biggest market driver.
  • Overall, as more states and countries move to legalize cannabis, cannabis is expected to flourish and become the next disruptive global market.
  • The investors see the potential for the cannabis industry despite the market being in a very grey area, legally.
  • HEXO Corp. (NYSE: HEXO) (TSX: HEXO) is an award-winning consumer packaged goods cannabis company that creates and distributes prize-winning products to serve the global cannabis market.

Global Cannabis Sativa Extract (CAS 89958-21-4) Market Research Report 2019 - ResearchAndMarkets.com

Retrieved on: 
Thursday, March 21, 2019
Health, Alternative medicine, Pharmaceutical, Natural Resources, Agriculture, Entheogens, Euphoriants, Medicinal plants, Plants, Medicine, Herbalism, Health sciences, Cannabis smoking, Cannabis, Medical cannabis, Effects of cannabis

The "Cannabis sativa extract (CAS 89958-21-4) Market Research Report 2019" report has been added to ResearchAndMarkets.com's offering.

Key Points: 
  • The "Cannabis sativa extract (CAS 89958-21-4) Market Research Report 2019" report has been added to ResearchAndMarkets.com's offering.
  • This Global Report 2019 is a result of industry experts' diligent work on Researching the world market of Cannabis sativa extract.
  • The forth chapter deals with Cannabis sativa extract market trends review, distinguish Cannabis sativa extract manufacturers and suppliers.
  • The Cannabis sativa extract global market Report 2019 key points:

Growpacker Hires ICR as Agency of Record

Retrieved on: 
Thursday, March 21, 2019
Natural Resources, Agriculture, Other Natural Resources, Retail, Food, Beverage, Specialty, Drugs, Appetite stimulants, Entheogens, Euphoriants, Antiemetics, Tetrahydrocannabinol, Neurochemistry, Medical specialties

Growpacker Inc. (Growpacker or the Company), a contract manufacturer of various THC- and CBD-infused edibles and beverages in the United States, announced today that it has named ICR as its PR and corporate communications agency of record.

Key Points: 
  • Growpacker Inc. (Growpacker or the Company), a contract manufacturer of various THC- and CBD-infused edibles and beverages in the United States, announced today that it has named ICR as its PR and corporate communications agency of record.
  • In this role, ICR will provide integrated counsel and support to Growpacker as the Company introduces its turnkey, industrial-scale co-packing platform to brands of all types, including large Consumer Packaged Goods (CPG) companies.
  • Growpacker intends to be a best-in-class provider of formulation, manufacturing and distribution services to help THC and CBD brands expand at scale.
  • ICR also advises on capital markets transactions through ICR Capital, LLC.

CannaDayz, a Two-Day Medical Marijuana Expo to Take Place This April 13-14, 2019 in South Florida

Retrieved on: 
Thursday, March 21, 2019
Cannabis, Cannabis smoking, Entheogens, Euphoriants, Drugs, Medicine

MIAMI, March 21, 2019 /PRNewswire/ --South Florida-Based Marketing Company CEMG willhost CannaDayz this April 2019.

Key Points: 
  • MIAMI, March 21, 2019 /PRNewswire/ --South Florida-Based Marketing Company CEMG willhost CannaDayz this April 2019.
  • The two-day bilingual (English/Spanish) medical cannabis expo will provide education, and networking to medical professionals, patients, caregivers, cannabis enthusiasts, investors, or anyone interested in the medical cannabis industry.
  • This exciting event announcement comes on the heels of Florida Gov.
  • Ron DeSantis signing a bill Monday, that now makes smokable medical marijuana legal in the Sunshine State.

Supreme Cannabis' 7ACRES Facility Approved for Additional 60,000 Square Feet of Production Capacity

Retrieved on: 
Thursday, March 21, 2019
Medicinal plants, Entheogens, Euphoriants, Medicine, Herbalism, Health sciences, Plants, Cannabis, Medical cannabis

TORONTO, March 21, 2019 /PRNewswire/ - The Supreme Cannabis Company , Inc. ("Supreme Cannabis" or the "Company") (TSX: FIRE) (OTCQX: SPRWF) (FRA: 53S1) today announced that its wholly-owned subsidiary, 7ACRES , has obtained Health Canada approval for six additional flowering rooms totaling 60,000 sqft of additional production space at its facility in Kincardine, Ontario.

Key Points: 
  • TORONTO, March 21, 2019 /PRNewswire/ - The Supreme Cannabis Company , Inc. ("Supreme Cannabis" or the "Company") (TSX: FIRE) (OTCQX: SPRWF) (FRA: 53S1) today announced that its wholly-owned subsidiary, 7ACRES , has obtained Health Canada approval for six additional flowering rooms totaling 60,000 sqft of additional production space at its facility in Kincardine, Ontario.
  • Total flowering room space at 7ACRES increases from 120,000 sqft to 180,000 sqft and 7ACRES' annual production capacity estimate increases from approximately 17,500kg to 26,250kg.
  • As noted in previous communications, Supreme Cannabis expects that with further production efficiencies following the licensing of all 25 flowering rooms, 7ACRES' potential capacity is anticipated to reach approximately 50,000kg per year by mid-2019.
  • With 18 of 25 flowering rooms at 7ACRES now approved by Health Canada, production space at our facility is near the finish line," said John Fowler, President and Founder of Supreme Cannabis.